SCHEMBL5455812

SCHEMBL5455812

NC(=O)c1c(NC(=O)Nc2ccc(OC(F)(F)F)cc2)sc2c1CCCC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
MEN1 O00255 3/20 0.58
ALDH1A1 P00352 3/20 0.58
KMT2A Q03164 3/20 0.58
GAA P10253 2/20 0.58
TLR2 O60603 3/20 0.56
FLT3 P36888 8/20 0.55
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
EPHX2 P34913 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
KCNH2 Q12809 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8289442 0.86 FLT3 (0.74) MAPTMEN1ALDH1A1KMT2AFLT3
SCHEMBL5453475 0.86 ANO1 (0.65) MAPTMEN1ALDH1A1KMT2AGAA
SCHEMBL5455906 0.86 FLT3 (0.74) MAPTMEN1ALDH1A1KMT2ATLR2
SCHEMBL8288696 0.85 FLT3 (0.73) MAPTMEN1ALDH1A1KMT2AFLT3
SCHEMBL5452297 0.85 TNIK (0.54) MAPTEPHX2KCNH2ANO1
SCHEMBL5455065 0.84 MEN1 (0.79) MAPTMEN1ALDH1A1KMT2AGAA
SCHEMBL5455220 0.84 MAPT (0.59) MAPTALDH1A1TP53NPC1RAB9A
SCHEMBL5455976 0.84 KMT2A (0.64) MAPTMEN1ALDH1A1KMT2AGAA
SCHEMBL8289838 0.84 RAB9A (0.72) MAPTMEN1ALDH1A1KMT2AFLT3
SCHEMBL4234573 0.83 FLT3 (0.72) MAPTMEN1ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 MAPT 21/4885MEN1 2891/4885ALDH1A1 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.